{
  "@context": "aku-v2",
  "@type": "pharmacology",
  "@id": "vasc:pharmacology:pharm-002-protamine",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T02:55:00.000Z",
    "updated": "2026-01-07T02:55:00.000Z",
    "contributors": [
      "vascular-surgery-agent"
    ],
    "confidence": 0.93,
    "status": "enhanced",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pharmacology/anticoagulation",
    "type": "pharmacology",
    "difficulty": "intermediate",
    "importance": "supportive"
  },
  "content": {
    "title": "Protamine Sulfate Reversal",
    "description": "Positively charged polypeptide that neutralizes heparin by ionic binding, used to reverse heparin anticoagulation after vascular procedures.",
    "mechanism": "Protamine (highly cationic) binds heparin (highly anionic) forming inactive complex. Does NOT reverse anti-Xa activity of LMWH well.",
    "dosing": {
      "for_UFH": "1mg protamine per 100 units heparin given in previous 2-3 hours",
      "max_dose": "50mg at a time (slow infusion)",
      "rate": "No faster than 5mg/min"
    },
    "pharmacokinetics": {
      "onset": "5 minutes",
      "duration": "~2 hours",
      "metabolism": "Degraded by circulating proteinases"
    },
    "adverse_effects": {
      "hypotension": "Most common, from histamine release",
      "anaphylaxis": "Risk factors: prior protamine, fish allergy, NPH insulin",
      "pulmonary_hypertension": "From heparin-protamine complexes",
      "paradoxical_anticoagulation": "Excess protamine has weak anticoagulant effect"
    },
    "clinical_considerations": {
      "partial_reversal": "Often 50% dose given to maintain some anticoagulation",
      "rebounding": "Heparin effect may return if protamine clears before residual heparin",
      "check_act": "Confirm adequate reversal before closing"
    },
    "lmwh_reversal": "Only partially reverses LMWH; consider fresh frozen plasma, prothrombin complex",
    "statement": "Protamine Sulfate Reversal is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pharmacology Anticoagulation that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Protamine Sulfate Reversal helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Protamine Sulfate Reversal include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Protamine Sulfate Reversal."
    }
  },
  "relationships": {
    "related_to": [
      "vasc:pharmacology:pharm-001-heparin",
      "vasc:procedures:surgical-hemostasis"
    ],
    "reverses": [
      "vasc:pharmacology:pharm-001-heparin"
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Protamine Sulfate Reversal. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}